Cargando…
Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity?
A lot of diseases, including lupus profundus, morphea, lipodystrophy, and Parry-Romberg syndrome, may manifest progressive hemifacial atrophy. These diseases usually progress slowly and rapid progression of atrophy is extremely rare. We report a case of elderly-onset rapid progression of hemifacial...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561931/ https://www.ncbi.nlm.nih.gov/pubmed/26380125 http://dx.doi.org/10.1155/2015/478640 |
_version_ | 1782389089285177344 |
---|---|
author | Nomura, Hisashi Egami, Shohei Yokoyama, Tomoaki Sugiura, Makoto |
author_facet | Nomura, Hisashi Egami, Shohei Yokoyama, Tomoaki Sugiura, Makoto |
author_sort | Nomura, Hisashi |
collection | PubMed |
description | A lot of diseases, including lupus profundus, morphea, lipodystrophy, and Parry-Romberg syndrome, may manifest progressive hemifacial atrophy. These diseases usually progress slowly and rapid progression of atrophy is extremely rare. We report a case of elderly-onset rapid progression of hemifacial atrophy only in three weeks. Our case did not meet variable differential diagnoses. We discuss the clinical character of the patient against the past of literature and suppose it may be a new clinical entity. |
format | Online Article Text |
id | pubmed-4561931 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-45619312015-09-15 Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity? Nomura, Hisashi Egami, Shohei Yokoyama, Tomoaki Sugiura, Makoto Case Rep Dermatol Med Case Report A lot of diseases, including lupus profundus, morphea, lipodystrophy, and Parry-Romberg syndrome, may manifest progressive hemifacial atrophy. These diseases usually progress slowly and rapid progression of atrophy is extremely rare. We report a case of elderly-onset rapid progression of hemifacial atrophy only in three weeks. Our case did not meet variable differential diagnoses. We discuss the clinical character of the patient against the past of literature and suppose it may be a new clinical entity. Hindawi Publishing Corporation 2015 2015-08-25 /pmc/articles/PMC4561931/ /pubmed/26380125 http://dx.doi.org/10.1155/2015/478640 Text en Copyright © 2015 Hisashi Nomura et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Nomura, Hisashi Egami, Shohei Yokoyama, Tomoaki Sugiura, Makoto Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity? |
title | Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity? |
title_full | Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity? |
title_fullStr | Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity? |
title_full_unstemmed | Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity? |
title_short | Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity? |
title_sort | case of rapid progression of hemiatrophy on the face: a new clinical entity? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561931/ https://www.ncbi.nlm.nih.gov/pubmed/26380125 http://dx.doi.org/10.1155/2015/478640 |
work_keys_str_mv | AT nomurahisashi caseofrapidprogressionofhemiatrophyonthefaceanewclinicalentity AT egamishohei caseofrapidprogressionofhemiatrophyonthefaceanewclinicalentity AT yokoyamatomoaki caseofrapidprogressionofhemiatrophyonthefaceanewclinicalentity AT sugiuramakoto caseofrapidprogressionofhemiatrophyonthefaceanewclinicalentity |